Peptides for perimenopause and menopause: do any really help?

No peptide is approved for hot flashes

Hormone therapy and 3 nonhormone pills are the FDA-approved hot flash options. None of them is a peptide.

By the Peptide Science Desk Editorial TeamFact-checked against FDA and official sources · Not yet reviewed by a licensed clinician. How we check facts

Short answer: No peptide is FDA approved to treat hot flashes or other menopause symptoms. Some approved peptide drugs can still help women in midlife for other reasons: Wegovy and Zepbound for weight, and Forteo and Tymlos for weak bones after menopause. Peptides sold online, like BPC-157 or CJC-1295, have no menopause studies in people.
Aerial view of the large brick NIH Clinical Center hospital buildings in Bethesda
The NIH Clinical Center in Bethesda, Maryland, a research hospital where many clinical trials take place.Photo: National Institutes of Health, public domain

Are peptides good for menopause?

  • It depends on what you want help with. No peptide is FDA approved for menopause itself.
  • A few approved peptide drugs treat problems that are common after 40, like extra weight or thin bones.
  • We found no menopause studies in people for peptides sold online, like BPC-157, CJC-1295 or ipamorelin. That means nobody knows if they help or harm.
  • FDA status, proof that it works, and safety are 3 different questions. We rate each one on its own below.

Do peptides help with perimenopause?

  • Perimenopause is the time before menopause when hormone levels change. It usually starts in your mid- to late 40s and lasts about 4 years on average, but it can last up to 10 years, says womenshealth.gov.
  • No peptide is FDA approved for perimenopause symptoms. We found no perimenopause trials in people for peptides sold online, like BPC-157 or CJC-1295.
  • Your doctor can usually tell if you are in perimenopause from your age, symptoms and periods. Blood hormone tests are not usually needed, says womenshealth.gov.
  • You can still get pregnant in perimenopause. That matters for GLP-1 drugs: the Wegovy label says to stop it at least 2 months before a planned pregnancy, and the Zepbound label says it can make birth control pills work less well for 4 weeks after you start and after each dose increase.

Do peptides help with hot flashes?

  • No peptide is FDA approved for hot flashes or night sweats.
  • The FDA has approved hormone therapy for moderate to severe hot flashes, says the Office on Women’s Health (womenshealth.gov).
  • The FDA has also approved 3 nonhormone medicines for moderate to severe hot flashes: a low-dose paroxetine (Brisdelle), fezolinetant (Veozah) and elinzanetant (Lynkuet). None of these is a peptide.
  • Each one has its own risks. The Veozah label has a boxed warning about liver injury and asks for liver blood tests. The Brisdelle label has a boxed warning about suicidal thoughts, like other SSRIs.
  • Talk therapy (CBT) and clinical hypnosis may also help hot flashes bother you less, says womenshealth.gov.

What peptides help with menopause weight gain and belly fat?

  • Wegovy (semaglutide) and Zepbound (tirzepatide) are peptide drugs. The FDA approved them for adults with obesity, or with overweight and a weight-related health problem. They are not approved for menopause itself.
  • In the STEP 1 trial, adults on the semaglutide shot lost about 14.9% of their weight in 68 weeks, vs 2.4% on placebo. That trial was not only for women in menopause.
  • Tesamorelin (Egrifta SV) lowers deep belly fat, but it is approved only for adults with HIV who have that problem.
  • No peptide is approved for "menopause belly fat."

Can peptides help bones after menopause?

  • Yes, 2 peptide drugs are FDA approved for this. Forteo (teriparatide) and Tymlos (abaloparatide) treat osteoporosis (thin, weak bones) in women after menopause who have a high chance of breaking a bone.
  • In a big trial, new spine fractures happened in about 14 of 100 women on placebo, vs about 5 of 100 on teriparatide.
  • In another big trial, women on abaloparatide had fewer new spine fractures than women on placebo.
  • The Forteo label says its most common side effects are joint pain, pain and nausea. The Tymlos label lists extra calcium in the urine, dizziness, nausea, headache, a pounding heartbeat, tiredness, upper belly pain and a spinning feeling.
  • These are shots that a doctor must prescribe.

Do peptides help low sex drive in menopause?

  • Vyleesi (bremelanotide, also called PT-141) is an FDA-approved peptide for low sexual desire that causes distress. But it is approved only for women who have not gone through menopause yet.
  • The Vyleesi label says it is not for women after menopause and not for men.
  • Its trials tested women before menopause. The average age was 39.

Are peptides safe for women over 40 and 50?

  • Approved peptide drugs have known risks on their FDA labels. Your doctor can check them against your health.
  • Most peptides sold online have very little safety data. No data does not mean safe. It also does not prove they fail. It means the risks are unknown.
  • The FDA has put some peptides on a list of bulk drug ingredients that may have serious safety risks.
  • "Not FDA approved" is not always the same as illegal. It depends on what the product is and how it is sold. See our legal guide.

Did the FDA change the hormone therapy warnings?

  • Yes. In November 2025, the FDA started removing boxed warnings about heart disease, breast cancer and dementia from menopause hormone therapy labels.
  • On February 12, 2026, the FDA approved the first 6 updated labels. The boxed warning about cancer of the uterus lining stays for estrogen-only pills and patches taken for the whole body.
  • Hormone therapy is not a peptide. It still has risks, like blood clots and stroke, says womenshealth.gov. Ask your doctor what fits you.

Do collagen peptides or skin peptide creams help after menopause?

  • Collagen peptide powders are sold as supplements. The FDA does not approve supplements before they are sold.
  • Skin creams are cosmetics. The FDA says cosmetics (except color additives) do not need FDA approval before sale.
  • The FDA says a cream that claims to regrow hair or "regenerate cells" is treated as a drug, not just a cosmetic.
  • We found no FDA-approved peptide cream or powder for menopause.

The numbers in charts

Weight loss in big obesity drug trials

% of starting body weight lost, drug vs placebo (fake shot)

Different trials, different people: not a head-to-head comparison.

Show the numbers as a table
Weight loss in big obesity drug trials: % of starting body weight lost, drug vs placebo (fake shot)
TrialDrugPlacebo
Tirzepatide 15 mg (Zepbound)
SURMOUNT-1 · 2,539 adults · 72 weeks
−20.9%−3.1%
Semaglutide 2.4 mg (Wegovy)
STEP 1 · 1,961 adults · 68 weeks
−14.9%−2.4%
Liraglutide 3.0 mg (Saxenda)
SCALE · 3,731 adults · 56 weeks
−7.4%−3.0%
Mean % change in body weight at each trial's main endpoint. The liraglutide percentages come from the Saxenda FDA label (Table 4, Study 1); the trial paper gives the number of adults and the length. Sources: Jastreboff et al., NEJM 2022 (SURMOUNT-1) (PMID 35658024); Wilding et al., NEJM 2021 (STEP 1) (PMID 33567185); Pi-Sunyer et al., NEJM 2015 (SCALE) (PMID 26132939); Saxenda FDA label, Table 4, Study 1 (DailyMed).

New spine fractures on bone-building shots

% of women with weak bones who got a new spine fracture, drug vs placebo

Different trials, different people: not a head-to-head comparison. Lower is better.

Show the numbers as a table
New spine fractures on bone-building shots: % of women with weak bones who got a new spine fracture, drug vs placebo
TrialDrugPlacebo
Teriparatide 20 µg (Forteo)
1,637 women · about 21 months
5%14%
Abaloparatide (Tymlos)
ACTIVE · 1,401 women in this count · 18 months
0.6%4.2%
Teriparatide numbers are from the trial paper. Abaloparatide numbers are from the Tymlos FDA label (Table 3: 690 women on the drug vs 711 on placebo). Both trials were paid for by the drug makers. Sources: Neer et al., NEJM 2001 (PMID 11346808); Tymlos FDA label, section 14, Table 3 (DailyMed); Miller et al., JAMA 2016 (ACTIVE) (PMID 27533157).

More charts: Peptides by the numbers

Studies in people

Big trials of approved peptide drugs, plus the best human review we found for BPC-157. We found no menopause trial for any peptide sold online.

Study typePeopleMain findingLimits
Randomized trial: teriparatide (Forteo) vs placebo, 20011,637 women after menopause who had broken a spine boneNew spine fractures: about 14% on placebo vs 5% on teriparatideWomen already had fractures; about 21 months
Randomized trial: abaloparatide (Tymlos) vs placebo (ACTIVE), 20162,463 women after menopause with osteoporosisFewer new spine and other fractures than placebo18 months; the teriparatide group was not blinded
Randomized trial: semaglutide shot vs placebo (STEP 1), 20211,961 adults with obesity or overweightWeight went down 14.9% vs 2.4% in 68 weeksNot a menopause study
2 randomized trials: bremelanotide (Vyleesi) vs placebo (RECONNECT), 20191,267 women before menopause (1,247 got at least one dose), average age 39More sexual desire and less distress than placeboNot tested after menopause
Review of all human studies: BPC-157, 20263 small studies, 30 people in totalMost people said they felt betterPoor-quality studies; none about menopause

Menopause options: FDA status, proof and safety

FDA statusProof it works in peopleSafety data
Hormone therapy (not a peptide)Approved for hot flashes, bone loss and vaginal drynessStrong for those usesWell studied; labels list risks
Brisdelle, Veozah, Lynkuet (not peptides)Approved for moderate to severe hot flashesEnough for FDA approvalLabels list risks; Veozah has a liver warning
Wegovy, Zepbound (peptides)Approved for weight in adults with obesity, not for menopause itselfStrong for weight lossWell studied
Forteo, Tymlos (peptides)Approved for weak bones after menopauseStrong: fewer spine fracturesWell studied
Vyleesi / PT-141 (peptide)Approved only before menopause, for low desireSome, before menopause onlyStudied before menopause only
BPC-157, CJC-1295, ipamorelin (peptides)Not FDA approvedNo menopause studies in peopleVery little
Check any peptide in 1 secondFree FDA Status Checker: approved, being tested, or not proven.

FAQ

Can GLP-1s help with perimenopause weight gain?

Wegovy and Zepbound are approved for adults with obesity, or with overweight and a weight-related health problem, at any adult age. They are not approved for perimenopause itself, and we found no big trial done only in women in perimenopause. Ask your doctor if you qualify.

Is GLP-1 microdosing good for perimenopause?

We found no published study of GLP-1 "microdosing" in perimenopause (PubMed search, Nov 2, 2026). Using doses outside the FDA label is something to decide only with your doctor.

Can a peptide replace estrogen?

No. No peptide is approved to replace estrogen or progesterone. Ask your doctor which approved choice fits your symptoms and health history.

Is testosterone approved for women in menopause?

No. Womenshealth.gov says the FDA has not approved testosterone for women. Some doctors still talk about it with patients, so ask about the risks.

Is kisspeptin used for menopause?

Kisspeptin-10 is not FDA approved for any use. It is still on the FDA list of risky bulk ingredients for regular pharmacies.

Does PT-141 work after menopause?

It was not tested after menopause in its main trials, and its FDA label says it is not for that group. So nobody knows.

Who can I call with menopause questions?

The Office on Women’s Health helpline is 1-800-994-9662, weekdays 9 a.m. to 6 p.m. Eastern. It shares information but does not give medical advice.

Are Forteo and Tymlos for everyone with low bone density?

No. They are approved for women after menopause with osteoporosis who have a high chance of breaking a bone, or when other bone drugs did not work or were not tolerated.

Related pages

We never share doses or tell you where to buy. Always ask your doctor. Print our doctor questions sheet.

Sources

Not medical advice. Medical disclaimer.